This research examines genetic resistance to infectious disease using plant models. Instead of a single gene controlling resistance, the study shows that multiple genes interact to produce diverse defense responses among individuals. Understanding this complex genetic resistance system may help explain why some organisms—including humans—are naturally resistant to infection.

This research addresses antibiotic resistance by developing new compounds effective against Pseudomonas aeruginosa. Using engineered Streptomyces albus, it produces uridyl peptide antibiotics with a triple-target mechanism that reduces resistance risk. The work focuses on purification and chemical optimization to create more effective, clinically viable antibiotics for future infections.

Chickenpox is usually harmless, yet the same virus can cause severe brain infections in some individuals. This research shows that a genetic variant in an immune-system gene reduces antiviral defense, allowing greater viral replication. Identifying such variants helps explain individual vulnerability to severe viral disease.

Gamma herpesviruses infect up to 95% of humans and can cause cancer, yet lack effective treatments. Using super-resolution microscopy, this research overturns the classic model of viral exit, revealing that herpesviruses build internal transport structures to escape cells efficiently—reshaping how we understand infection and opening new therapeutic possibilities.